Farma Medis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day). AptameX delivers sensitivity of 77% (95% CI: 75.94 - 79.24) at a high industry CT score of 28.3, which is comparable to current lateral flow rapid tests. Moving to complete product registration in Indonesia and progressing to securing a CE mark in Europe with a view to approvals and sales in Q3 2021. ZURICH, GERMANY / ACCESSWIRE / May 20, 2021 / Achiko AG (SWX:ACHI, ISIN CH0522213468) completed production of the first 1,000 AptameX test kits and has commenced shipme...

May 20, 2021 Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day). AptameX delivers sensitivity of 77% (95% CI: 75.94 - 79.24) at a high industry CT score of 28.3, which is comparable to current lateral flow rapid tests. Moving to complete product registration in Indonesia and progressing to securing a CE mark in Europe with a view to approvals and sales in Q3 2021. ZURICH, SWITZERLAND - EQS Newswire - 20 May 2021 -  Achiko AG (SWX:ACHI, ISIN CH0522213468) completed production of the first 1,000 AptameX test kits and h...

Achiko AG / Key word(s): Preliminary Results Achiko AG: Achiko completes initial shipment of AptameX, its progressive Covid-19 diagnostic test, to Indonesia, delivering 77% sensitivity at low viral loads 20-May-2021 The issuer is solely responsible for the content of this announcement.   Achiko completes initial shipment of AptameX, its progressive Covid-19 diagnostic test, to Indonesia, delivering 77% sensitivity at low viral loads - Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000...

Novel diagnostic test for COVID-19 by Achiko enters Indonesia Novel diagnostic test for COVID-19 by Achiko enters Indonesia 30 April 2021 | News Source: achiko Swiss firm Achiko AG's joint venture partner PT Indonesia Farma Medis (IFM) has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX. This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration facilitating th...

Achiko AG: Achiko's Joint Venture Partner Obtains A Distribution Certificate for Aptamex, A Novel Diagnostic Test for Covid-19 In Indonesia, And Commences Product Registration Achiko subsequently commenced product registration with its partners with a view to mid-year commercial product availability Achiko to generate revenues on a 50% holding of the joint venture and a 10% licensing fee from gross sales ZURICH, SWITZERLAND / ACCESSWIRE / April 29, 2021 / Achiko AG's (SWX:ACHI, ISIN CH0522213468) joint venture partner PT Indonesia Farma Medis ("IFM") has been granted a medical device distribu...